The State of Ovarian Cancer: How Ovarian Cancer Care is Evolving in the COVID-19 Pandemic

An OncLive^® Weekly Webinar Series highlighting best practices, treatment updates, and multidisciplinary approaches to ovarian cancer care through the COVID-19 Pandemic.

Objectives:

Impact of the COVID-19 pandemic on the diagnosis and screening of patients with ovarian cancer

Navigating through challenging treatment decisions for patients with ovarian cancer during the pandemic

How clinical trials have been affected and the expanding role of telemedicine

Thomas J. Herzog, MD

Thomas J. Herzog, MDD

Faculty: Thomas J. Herzog, MD

Clinical Director University of Cincinnati Cancer Institute

Professor of Obstetrics and Gynecology, UC College of Medicine

Bradley Monk, MD, FACOG, FACS

Bradley Monk, MD, FACOG, FACS

Bradley Monk, MD, FACOG, FACS

Professor, Division of Gynecologic Oncology

Arizona Oncology (US Oncology Network)

University of Arizona College of Medicine

Creighton University School of Medicine at St. Joseph's Hospital Phoenix, USA

Medical Director, US Oncology Research Network - Gynecologic Program

Co-director GOG-Partners

Member Board of Director GOG-Foundation

Jubilee Brown, MD

Jubilee Brown, MD

Jubilee Brown, MD

Professor of Gynecologic Oncology

Associate Director of Gynecologic Oncology

Levine Cancer Institute, Atrium Health

Laura Musselwhite, MD

Laura Musselwhite, MD

Laura Musselwhite, MD

Medical Oncologist

Director of Outcomes Research, Department of Solid Tumor Oncology

Levine Cancer Institute

Sponsored by: Clovis

Clovis